HK1014670A1 - Biotin compounds for targetting tumors and sites of infection. - Google Patents
Biotin compounds for targetting tumors and sites of infection.Info
- Publication number
- HK1014670A1 HK1014670A1 HK98116076A HK98116076A HK1014670A1 HK 1014670 A1 HK1014670 A1 HK 1014670A1 HK 98116076 A HK98116076 A HK 98116076A HK 98116076 A HK98116076 A HK 98116076A HK 1014670 A1 HK1014670 A1 HK 1014670A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- targetting
- tumors
- infection
- sites
- biotin compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
- A61K47/557—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells the modifying agent being biotin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0495—Pretargeting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25426094A | 1994-06-06 | 1994-06-06 | |
US26551694A | 1994-06-24 | 1994-06-24 | |
PCT/US1995/007184 WO1995033491A1 (en) | 1994-06-06 | 1995-06-05 | Biotin compounds for targetting tumors and sites of infection |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1014670A1 true HK1014670A1 (en) | 1999-09-30 |
Family
ID=26943939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98116076A HK1014670A1 (en) | 1994-06-06 | 1998-12-28 | Biotin compounds for targetting tumors and sites of infection. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0769966B1 (de) |
JP (2) | JP4013996B2 (de) |
AT (1) | ATE268186T1 (de) |
AU (1) | AU700864B2 (de) |
CA (1) | CA2192384A1 (de) |
DE (1) | DE69533105T2 (de) |
HK (1) | HK1014670A1 (de) |
WO (1) | WO1995033491A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20030269A1 (it) * | 2003-02-14 | 2004-08-15 | Advance Holdings Ltd | Sale di cetilpiridino di un agente antiinfiammatorio |
CN110183504B (zh) * | 2019-06-13 | 2023-07-07 | 湖南大学 | 一种具有肿瘤靶向性的吉西他滨前体药物及其制备方法和用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5108921A (en) * | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
US5258126A (en) * | 1989-09-12 | 1993-11-02 | Pall Corporation | Method for obtaining platelets |
DE4011601A1 (de) * | 1990-04-10 | 1991-10-17 | Boehringer Mannheim Gmbh | Hapten-biotin-konjugate und ihre verwendung |
US5326778A (en) * | 1992-03-03 | 1994-07-05 | Research Corporation Technologies, Inc. | Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy |
EP1138334A3 (de) * | 1992-06-09 | 2002-04-03 | Neorx Corporation | Pretargeting Verfahren und Mitteln |
US5578287A (en) * | 1992-06-09 | 1996-11-26 | Neorx Corporation | Three-step pretargeting methods using improved biotin-active agent |
-
1995
- 1995-06-05 DE DE69533105T patent/DE69533105T2/de not_active Expired - Fee Related
- 1995-06-05 AT AT95922233T patent/ATE268186T1/de not_active IP Right Cessation
- 1995-06-05 JP JP50128396A patent/JP4013996B2/ja not_active Expired - Fee Related
- 1995-06-05 WO PCT/US1995/007184 patent/WO1995033491A1/en active IP Right Grant
- 1995-06-05 EP EP95922233A patent/EP0769966B1/de not_active Expired - Lifetime
- 1995-06-05 CA CA002192384A patent/CA2192384A1/en not_active Abandoned
- 1995-06-05 AU AU26991/95A patent/AU700864B2/en not_active Ceased
-
1998
- 1998-12-28 HK HK98116076A patent/HK1014670A1/xx not_active IP Right Cessation
-
2007
- 2007-07-13 JP JP2007183924A patent/JP2007302686A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2192384A1 (en) | 1995-12-14 |
DE69533105D1 (de) | 2004-07-08 |
JP4013996B2 (ja) | 2007-11-28 |
AU700864B2 (en) | 1999-01-14 |
DE69533105T2 (de) | 2005-06-09 |
JP2007302686A (ja) | 2007-11-22 |
JPH10508003A (ja) | 1998-08-04 |
WO1995033491A1 (en) | 1995-12-14 |
ATE268186T1 (de) | 2004-06-15 |
AU2699195A (en) | 1996-01-04 |
EP0769966B1 (de) | 2004-06-02 |
EP0769966A1 (de) | 1997-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP9600804A0 (en) | Therapeutic amides. | |
IL107207A0 (en) | Sustained release pharmaceutical compositions | |
HUP0002760A3 (en) | Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors | |
ZA946123B (en) | Methods for modulating the human sexual response | |
BG101540A (en) | Interferon conjugates | |
HU9601741D0 (en) | Use of pla2 inhibitors as treatment for alzheimer's disease | |
UA39158C2 (uk) | Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі | |
EP0761173A3 (de) | Nadel zum Verabreichen therapeutischer Lösungen in den Subarachnoidalraum | |
EP0942742A4 (de) | Therapeutische zusammensetzungen zur krebsbehandlung | |
HK1018742A1 (en) | Preparation containing a combination of 5-methylisoxazole-4-carboxyclic acid-(4-triflouromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide | |
HUP9902806A3 (en) | Use of cis-n-cyclohexyl-n-ethyl-[3-(3-chloro-4-cyclohexylphenyl)allyl]amine to produce drugs for preventing tumour proliferation | |
MY121623A (en) | Methods of preventing breast cancer. | |
IL134263A0 (en) | Use of phanquinone for the treatment of alzheimer's disease | |
MY118244A (en) | Alfa-amino acid amides, preparation thereof and the therapeutical use thereof | |
GB9509888D0 (en) | Terpenoidic derivatives useful as antitumour agents | |
HK1014670A1 (en) | Biotin compounds for targetting tumors and sites of infection. | |
IL141936A0 (en) | Antibodies to c3b(1) for delivery of diagnostic and therapeutic agents to cancer cells | |
AP9200355A0 (en) | "Therapeutic agent" | |
EP0302263A3 (en) | Therapeutic composition for combatting aids | |
MY119140A (en) | Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors | |
GB9013868D0 (en) | Spinal traction machine for self-application of traction | |
DE3374066D1 (en) | N-acyl derivatives of peptides, their manufacture and use in combating diseases and means therefor | |
ES8506643A1 (es) | Procedimiento para la preparacion de derivados d,l-, d-y l-del acido 3-imidazolil-2-amino-propionico | |
GB2266241B (en) | Treatment of pastures | |
AP9600780A0 (en) | Process for the preparation of peroxetine hydrochloride anhydrate and its use as therapeutic agent. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20100605 |